Carregant...
Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
The coronavirus disease 2019 (COVID-19) pandemic is concerning for patients with neuroimmunological diseases who are receiving immunotherapy. Uncertainty remains about whether immunotherapies increase the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or increase...
Guardat en:
| Publicat a: | Nat Rev Neurol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7341707/ https://ncbi.nlm.nih.gov/pubmed/32641860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-0385-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|